Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Proqr Therapeutics (PRQR)

Proqr Therapeutics (PRQR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 198,065
  • Shares Outstanding, K 50,143
  • Annual Sales, $ 0 K
  • Annual Income, $ -63,560 K
  • 60-Month Beta 0.68
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.39
Trade PRQR with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.27
  • Number of Estimates 1
  • High Estimate -0.27
  • Low Estimate -0.27
  • Prior Year -0.35
  • Growth Rate Est. (year over year) +22.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.80 +3.95%
on 10/20/20
5.06 -21.94%
on 09/28/20
-1.05 (-21.00%)
since 09/25/20
3-Month
3.80 +3.95%
on 10/20/20
6.38 -38.09%
on 08/31/20
-1.10 (-21.78%)
since 07/24/20
52-Week
3.80 +3.95%
on 10/20/20
10.98 -64.03%
on 12/16/19
-3.30 (-45.52%)
since 10/25/19

Most Recent Stories

More News
ProQR Appoints Naveed Shams, MD, PhD as Chief Scientific Officer

ProQR Therapeutics N.V. (Nasdaq: PRQR) (the "Company"), a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs), today announced...

PRQR : 3.95 (-5.50%)
ProQR Announces Virtual Presentations at Scientific Conferences

ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced virtual presentations...

PRQR : 3.95 (-5.50%)
ProQR to Participate in Upcoming Investor Conferences

ProQR Therapeutics N.V. (Nasdaq: PRQR) (the "Company"), a company dedicated to changing lives through the creation of transformative RNA medicines for inherited retinal diseases (IRDs), today announced...

PRQR : 3.95 (-5.50%)
ProQR: 2Q Earnings Snapshot

LEIDEN, Netherlands (AP) _ ProQR Therapeutics NV (PRQR) on Thursday reported a loss of $4.5 million in its second quarter.

PRQR : 3.95 (-5.50%)
The Zacks Analyst Blog Highlights: Smith & Wesson, Zscaler, Sportsman's Warehouse, ProQR and Ooma

The Zacks Analyst Blog Highlights: Smith & Wesson, Zscaler, Sportsman's Warehouse, ProQR and Ooma

PRQR : 3.95 (-5.50%)
SPWH : 13.87 (-1.03%)
OOMA : 14.50 (-2.75%)
ZS : 149.00 (+1.33%)
SWBI : 16.08 (-1.05%)
5 Must-Buy Low-Beta Stocks Flying High in a Volatile Market

At this stage, we have narrowed down our search to five low-beta stocks that have provided double-digit returns in the past month.

AAPL : 115.05 (+0.01%)
AMC : 2.75 (-7.41%)
PRQR : 3.95 (-5.50%)
SPWH : 13.87 (-1.03%)
OOMA : 14.50 (-2.75%)
ZS : 149.00 (+1.33%)
SWBI : 16.08 (-1.05%)
Zacks.com featured highlights include: Frontline, iClick Interactive Asia, Avenue Therapeutics, ProQR Therapeutics and BJ???s Wholesale Club

Zacks.com featured highlights include: Frontline, iClick Interactive Asia, Avenue Therapeutics, ProQR Therapeutics and BJ???s Wholesale Club

BJ : 39.54 (+1.20%)
FRO : 6.10 (-1.45%)
PRQR : 3.95 (-5.50%)
ICLK : 8.41 (-1.18%)
ATXI : 3.24 (-6.36%)
5 Low-Beta Stocks to Beat Renewed Coronavirus Concerns

To combat market volatility, it is of utmost importance to create a portfolio of low-beta stocks.

BJ : 39.54 (+1.20%)
FRO : 6.10 (-1.45%)
PRQR : 3.95 (-5.50%)
ICLK : 8.41 (-1.18%)
ATXI : 3.24 (-6.36%)
ProQR Announces Expert Perspectives Conference Call Series

ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced that the Company will...

PRQR : 3.95 (-5.50%)
ProQR Announces Virtual Presentation of Phase 1/2 Sepofarsen Data Through the Association for Research in Vision and Ophthalmology (ARVO)

ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced a virtual presentation...

PRQR : 3.95 (-5.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ProQR Therapeutics B.V. is a biotech company. It is engaged in the discovery and development of RNA-based therapeutics for the treatment of severe genetic disorders, with an initial focus on Cystic Fibrosis (CF). The Company's lead product candidate includes QR-010, a RNA-based oligonucleotide for the...

See More

Key Turning Points

2nd Resistance Point 4.32
1st Resistance Point 4.14
Last Price 3.95
1st Support Level 3.81
2nd Support Level 3.66

See More

52-Week High 10.98
Fibonacci 61.8% 8.24
Fibonacci 50% 7.39
Fibonacci 38.2% 6.54
Last Price 3.95
52-Week Low 3.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar